Fetal Heart: Screening, Diagnosis & Intervention (Paperback) by Cihat Sen, Milan Stenojevic

Congenital anomalies are the greatest contributor to the infant death and congenital heart diseases (chds) account for up to 50% of these deaths. Congenital heart diseases with the highest incidence of extracardiac abnormalities (>25%) included heterotaxy, single left ventricle and tricuspid atresia, hypoplastic left heart syndrome, and tetralogy of Fallot (toe). it is the most common type of birth defect, accounting for one-third of all major congenital anomalies. For the clinicians and families, the major or critical cardiac defects carry the utmost importance since they may be either lethal or may require intervention in infancy of long-term follow-up. About 1.35 million infants are born with CHD each year, with a worldwide occurrence of 7 per 1, 000 live births. Prenatal detection of critical chds may help to enhance perinatal Counselling and delivery planning. The fatal heart examination should be used in the evaluation of all foetuses carrying low risk for CHD. The fatal heart examination to maximise the detection of heart anomalies during a second-trimesters scan in all foetuses and this examination should be an integral part of routine prenatal care. Fatal heart: screening, diagnosis, and intervention is giving the means for the screening of the heart defect in both first and second Trimesters. This will help healthcare professionals caring for the pregnant women at the basic level of care, performing prenatal anomaly scan screening.